Liver disease

Liver disease background banner.
Liver disease background banner.
Liver disease background banner.

The liver is the largest internal organ in the body and hepatic function is crucial to good health. A variety of analytes are designated as routine markers of liver disease. When used together in panels or individually, they can help detect and monitor hepatic disease.

For in vitro diagnostics use only.

Abbott liver function assays are designed to help evaluate liver health. Albumin is the major blood protein and is produced by the liver. Two dye binding assays, BCG and BCP, are used to measure albumin, which is decreased or increased in various diseases. The common liver enzymes ALT and AST are important markers for conditions such as hepatitis.

Hepatic malfunction is indicated by abnormal levels of direct and total bilirubin. Ammonia is a marker of acute liver failure and the enzyme GGT is associated with alcohol abuse and liver cirrhosis.  Bile acids produced by the liver are necessary to lipid metabolism.  All of these can be used to narrow and accurately assess disease states and treatment options. 

Core laboratory menu
Register or Login To your account to view assay specific package inserts for intended use and important safety information.
Some assays may not be available on all platforms.
View the Core laboratory menu To see the complete list of available assays and in development assays, categorized by instrument and segment.
Anti-HAV IgG
Anti-HAV IgM
Anti-HBc IgM
HBsAg (Qualitative Conf.)
HBsAg (Quantitative)
Liver Disease
Albumin (BCG)
Albumin (BCP)
Alkaline Phosphatase
Alpha-1 Antitrypsin
ALT (Alanine Aminotransferase)
ALT, Activated (Alanine Aminotransferase)
AST (Aspartate Aminotransferase)
AST, Activated (Aspartate Aminotransferase)
Bile Acids
Direct Bilirubin
GGT (Gamma-Glutamyl Transferase)
Lactate Dehydrogenase (LD)
Total Bilirubin
Related instruments

A unified approach


Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.

Hepatitis diagnostics

Committed to the hepatitis in vitro diagnostics community for over 40 years

Abbott scientists and market experts are continuously working together to solve today's challenges, understand future needs and eliminate gaps in the diagnosis of hepatitis infected patients and in our overall health care community. Abbott continues to research and invest in expanding hepatitis-testing options to a variety of diagnostic platforms.

hepatitis diagnostics background image
hepatitis diagnostics background image

Knowledge Center

Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

Mild Traumatic Brain Injury

Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).

Alinity Systems

Discover how Alinity uses technology to redefine and improve operational productivity and confidence in your laboratory.